1. Jan 21, 2021

    Antimalarials adherence lowers risk of death in systemic lupus erythematosus

    Patients with systemic lupus erythematosus (SLE) who adhered to antimalarials (AM) therapy lowered their risk of death by up to 71% compared to patients who did not adhere to AM therapy and 83% compared to those who discontinued AM, according to a study.

    A total of 3062 individuals with SLE who were treated with AM were included and followed from t…

VIDEOS

Conference Roundup

  1. Jan 20, 2021

Pembrolizumab shows promise in advanced HCC

Pembrolizumab monotherapy demonstrated durable anti-tumor activity and promising overall survival in patients with advanced hepatocellular carcinoma (HCC), according to study data presented at Gastrointestinal Cancers Symposium.

In…

Journal Scan

  1. Jan 21, 2021

Antimalarials adherence lowers risk of death in systemic lupus erythematosus

Patients with systemic lupus erythematosus (SLE) who adhered to antimalarials (AM) therapy lowered their risk of death by up to 71% compared to patients who did not adhere to AM therapy and 83% compared to those who discontinued AM, according to a study.